This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lipton, L. Articles by Tomlinson, I. P. M. Search for Related Content PubMed PubMed Citation Articles by Lipton, L. Articles by Tomlinson, I. P. M.

Carcinogenesis in MYH-Associated Polyposis Follows a Distinct Genetic Pathway

¹ Molecular and Population Genetics Laboratory, London Research Institute, Cancer Research United Kingdom, London, United Kingdom;
² Cancer Research United Kingdom Colorectal Cancer Unit, St. Mark’s Hospital, Harrow United Kingdom;
³ Department of Histopathology, University College London Hospitals, London, United Kingdom;
⁴ Danish Polyposis Registry, Hvidovre Hospital, Copenhagen, Denmark;
⁵ Department of Clinical Genetics, St. George’s Hospital Medical School, London, United Kingdom;
⁶ Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland

Colorectal carcinomas develop according to particular genetic pathways, including the chromosomal instability (CIN+), microsatellite instability (MSI+) and MSI- CIN- routes. We have determined the genetic pathway in patients with MYH-associated polyposis (MAP), a syndrome of colorectal adenomas and cancer that results from defective base excision repair (BER). As in previous studies, MAP tumors showed a high frequency of G>T mutations in APC, in accordance with defective BER. We found that K-ras mutations were common in MAP tumors, all of the changes comprising conversion of the first guanine residue of codon 12 to thymidine (G12C, GGT>TGT). We found no BRAF mutations at the codon 599 hotspot or elsewhere in exon 14. Almost all of the MAP cancers were near-diploid (CIN-), and none was MSI+. A few p53 mutations were found, but these were not predominantly G>T changes. p53 overexpression was, however, frequent. No SMAD4 or TGFBIIR mutations were found. MAP tumors appear to follow a distinct genetic pathway, with some features of both the CIN and MSI pathways. BER deficiency is rarely accompanied by CIN or MSI. The spectrum of somatic mutations in MAP tumors reflects both selection and hypermutation to which certain guanine residues are particularly prone.

This article has been cited by other articles:

				M. van Puijenbroek, M. Nielsen, C. M.J. Tops, H. Halfwerk, H. F.A. Vasen, M. M. Weiss, T. van Wezel, F. J. Hes, and H. Morreau Identification of Patients with (Atypical) MUTYH-Associated Polyposis by KRAS2 c.34G > T Prescreening Followed by MUTYH Hotspot Analysis in Formalin-Fixed Paraffin-Embedded Tissue Clin. Cancer Res., January 1, 2008; 14(1): 139 - 142. [Abstract] [Full Text] [PDF]

				H. Bai and A-L. Lu Physical and Functional Interactions between Escherichia coli MutY Glycosylase and Mismatch Repair Protein MutS J. Bacteriol., February 1, 2007; 189(3): 902 - 910. [Abstract] [Full Text] [PDF]

				M Nielsen, J W Poley, S Verhoef, M van Puijenbroek, M M Weiss, G T Burger, C J Dommering, H F A Vasen, E J Kuipers, A Wagner, et al. Duodenal carcinoma in MUTYH-associated polyposis J. Clin. Pathol., November 1, 2006; 59(11): 1212 - 1215. [Abstract] [Full Text] [PDF]

				J. Cardoso, L. Molenaar, R. X. de Menezes, M. van Leerdam, C. Rosenberg, G. Moslein, J. Sampson, H. Morreau, J. M. Boer, and R. Fodde Chromosomal Instability in MYH- and APC-Mutant Adenomatous Polyps. Cancer Res., March 1, 2006; 66(5): 2514 - 2519. [Abstract] [Full Text] [PDF]

				A. R. Parker, O. M. Sieber, C. Shi, L. Hua, M. Takao, I. P. Tomlinson, and J. R. Eshleman Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair Carcinogenesis, November 1, 2005; 26(11): 2010 - 2018. [Abstract] [Full Text] [PDF]

				V Johnson, L R Lipton, C Cummings, A T Eftekhar Sadat, L Izatt, S V Hodgson, I C Talbot, H J W Thomas, A J R Silver, and I P M Tomlinson Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families J. Med. Genet., October 1, 2005; 42(10): 756 - 762. [Abstract] [Full Text] [PDF]

				M Nielsen, P F Franken, T H C M Reinards, M M Weiss, A Wagner, H van der Klift, S Kloosterman, J J Houwing-Duistermaat, C M Aalfs, M G E M Ausems, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP) J. Med. Genet., September 1, 2005; 42(9): e54 - e54. [Abstract] [Full Text] [PDF]

				O. M. Sieber, K. M. Howarth, C. Thirlwell, A. Rowan, N. Mandir, R. A. Goodlad, A. Gilkar, B. Spencer-Dene, G. Stamp, V. Johnson, et al. Myh Deficiency Enhances Intestinal Tumorigenesis in Multiple Intestinal Neoplasia (ApcMin/+) Mice Cancer Res., December 15, 2004; 64(24): 8876 - 8881. [Abstract] [Full Text] [PDF]

				C. Oliveira, J. L. Westra, D. Arango, M. Ollikainen, E. Domingo, A. Ferreira, S. Velho, R. Niessen, K. Lagerstedt, P. Alhopuro, et al. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status Hum. Mol. Genet., October 1, 2004; 13(19): 2303 - 2311. [Abstract] [Full Text] [PDF]

				Z. Kemp, C. Thirlwell, O. Sieber, A. Silver, and I. Tomlinson An update on the genetics of colorectal cancer Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R177 - R185. [Abstract] [Full Text] [PDF]